Bottom line
What does GTHIX hold?
GTHIX held 82 positions as of Jul 31, 2026. Its largest holding is Eli Lilly and Co. at 10.59% of the fund, and the top 10 positions add up to 48.5%. By asset type it is 98% stocks, 9% cash & short-term funds.
Updated Sep 28, 2026
GTHIX top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Eli Lilly and Co. | Stocks | 10.59% | $127.9M |
| 2 | Johnson & Johnson | Stocks | 6.76% | $81.6M |
| 3 | UnitedHealth Group Inc. | Stocks | 6.17% | $74.4M |
| 4 | Invesco Private Prime Fund | Cash & short-term funds | 4.67% | $56.3M |
| 5 | Merck & Co., Inc. | Stocks | 4.59% | $55.4M |
| 6 | AbbVie Inc. | Stocks | 4.03% | $48.6M |
| 7 | Gilead Sciences, Inc. | Stocks | 3.63% | $43.9M |
| 8 | argenx SE argenx SE, ADR |
Stocks | 3.24% | $39.1M |
| 9 | CVS Health Corp. | Stocks | 2.52% | $30.4M |
| 10 | Welltower Inc. | Stocks | 2.34% | $28.2M |
| 11 | BrightSpring Health Services, Inc. | Stocks | 2.20% | $26.5M |
| 12 | Royalty Pharma PLC Royalty Pharma PLC, Class A |
Stocks | 2.13% | $25.8M |
| 13 | Cardinal Health, Inc. | Stocks | 2.10% | $25.3M |
| 14 | Guardant Health, Inc. | Stocks | 2.04% | $24.7M |
| 15 | Vertex Pharmaceuticals Inc. | Stocks | 2.01% | $24.3M |
| 16 | Invesco Private Government Fund | Cash & short-term funds | 1.80% | $21.7M |
| 17 | Axsome Therapeutics, Inc. | Stocks | 1.58% | $19.1M |
| 18 | Edwards Lifesciences Corp. | Stocks | 1.56% | $18.9M |
| 19 | Invesco Treasury Portfolio Invesco Treasury Portfolio, Institutional Class |
Cash & short-term funds | 1.56% | $18.8M |
| 20 | Thermo Fisher Scientific Inc. | Stocks | 1.55% | $18.7M |
| 21 | BridgeBio Pharma, Inc. | Stocks | 1.43% | $17.3M |
| 22 | Waters Corp. | Stocks | 1.41% | $17.0M |
| 23 | IQVIA Holdings Inc. | Stocks | 1.32% | $15.9M |
| 24 | U C B S.a. | Stocks | 1.24% | $15.0M |
| 25 | Ligand Pharmaceuticals Inc. | Stocks | 1.18% | $14.2M |
Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 28, 2026